Cargando…

Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations

Blood pressure control remains an unmet clinical need. Only about half of patients achieve their blood pressure (BP) targets and of these, the majority require combination and double or triple therapies. International guidelines recommend the association of drugs with complementary mechanisms of act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burnier, Michel, Redon, Josep, Volpe, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090015/ https://www.ncbi.nlm.nih.gov/pubmed/36696054 http://dx.doi.org/10.1007/s40292-023-00563-8

Ejemplares similares

Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
por: Uddin, Ijlal, et al.
Publicado: (2010)

Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill
por: Burnier, Michel
Publicado: (2010)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
por: Greathouse, Mark
Publicado: (2006)

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension
por: Niemeijer, Menco G., et al.
Publicado: (2009)

Management of Hypertension Using Olmesartan Alone or in Combination
por: Zhang, Xiaoshen, et al.
Publicado: (2017)

Olmesartan medoxomil for the treatment of hypertension in children and adolescents
por: Tocci, Giuliano, et al.
Publicado: (2011)

Role of olmesartan in combination therapy in blood pressure control and vascular function
por: Ferrario, Carlos M, et al.
Publicado: (2010)

Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors
por: Oh, Jaewon, et al.
Publicado: (2023)

Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment
por: Omboni, Stefano, et al.
Publicado: (2018)

Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
por: Punzi, Henry A
Publicado: (2011)

Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine
por: Pruijm, Menno T, et al.
Publicado: (2008)

The Effects of Single Pill Combinations on Adherence and Blood Pressure Control in Hypertensive Patients
por: Naser, Nabil, et al.
Publicado: (2022)

Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy
por: Rea, Federico, et al.
Publicado: (2023)

Comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patients
por: Yoshii, Hidenori, et al.
Publicado: (2011)

Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
por: Omboni, Stefano, et al.
Publicado: (2018)

Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination
por: Pimenta, Eduardo, et al.
Publicado: (2008)

Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)
por: Sohn, Il Suk, et al.
Publicado: (2021)

Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
por: Ruilope, Luis M
Publicado: (2008)

Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017)

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
por: Basile, Jan
Publicado: (2010)

Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis
por: Rakugi, Hiromi, et al.
Publicado: (2015)

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
por: Omboni, Stefano, et al.
Publicado: (2015)

Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform
por: Volpe, Massimo, et al.
Publicado: (2017)

Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan
por: Omboni, Stefano, et al.
Publicado: (2018)

Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study
por: Jadhav, Uday, et al.
Publicado: (2014)

Impact of a Pill Box Clinic to Improve Systolic Blood Pressure in Veterans with Uncontrolled Hypertension Taking 3 or More Antihypertensive Medications
por: Porter, Angela K., et al.
Publicado: (2014)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
por: Mason, R Preston
Publicado: (2011)

Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China
por: Gao, Pingjin, et al.
Publicado: (2015)

Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations
por: Levi, Miriam, et al.
Publicado: (2016)

Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient
por: Sarzani, Riccardo, et al.
Publicado: (2022)

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
por: Sohn, Il Suk, et al.
Publicado: (2015)

Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
por: Choi, JungMin, et al.
Publicado: (2021)

Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual‐Combination Therapy
por: Rump, Lars C., et al.
Publicado: (2015)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011)

Persistent olmesartan-based blood pressure–lowering effects on morning hypertension in Asians: the HONEST study
por: Kario, Kazuomi, et al.
Publicado: (2016)

Effects of Different Antihypertensive Drug Combinations on Blood Pressure and Arterial Stiffness
por: Jatic, Zaim, et al.
Publicado: (2019)

Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
por: Sohn, Il Suk, et al.
Publicado: (2016)

Safety of Fixed Dose of Antihypertensive Drug Combinations Compared to (Single Pill) Free-Combinations: A Nested Matched Case–Control Analysis
por: Nowak, Emmanuel, et al.
Publicado: (2015)

A double‐blind, placebo‐controlled trial on the antihypertensive treatment effect of a quadruple single‐pill combination
por: Hu, Lei‐Xiao, et al.
Publicado: (2021)

Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy
por: Punzi, Henry, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ef62ge6k6dubjuqlu8r3i12vm7